Clinical Trials
Braintumor Website

There are 5 trials:
Facility: University of Michigan Health System
NCT Trial Name# of Centers

NCT01480479

  Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
206

NCT02546102

  Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
64

NCT02073279

  Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD
59

NCT02650752

  Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
7

NCT02791425

  Brain Computer Interface for Communication in Ventilated Patients
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites